))
The Standard of Care for Metastatic Prostate Cancer
Manage episode 429329039 series 3585940
Konten disediakan oleh JNM. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh JNM atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
The VISION Trial is the first-in-its-field study to use radiopharmaceuticals that directly target prostate cancer tumors. Hear from one of the lead researchers on this ground-breaking study as he discusses how the trial has opened up a completely new field of study in prostate cancer research and shaped the future of nuclear medicine therapy in combatting the disease. Join us for Episode 4 of JNM Podcast from The Journal of Nuclear Medicine.
Moderators: Ken Herrmann, MD (Universitätsmedizin, Essen, Germany) and Heiko Schoder, MD, MBA (Memorial Sloan Kettering Cancer Center)
Panelist: Michael J. Morris, MD (Memorial Sloan Kettering Cancer Center)
Thank you to SOFIE Biosciences for sponsoring this episode. https://sofie.com/
6 episode
Bagikan
